Clinical Trial Update: Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency [Phase 3]

View source ↗

Summary

A Phase 3 study of IVIG-SN for primary immunodeficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Diseases

Drugs mentioned

• IVIG-SN

Snippet

Sponsor: Green Cross Corporation | Conditions: Immunologic Deficiency Syndrome | Phase 3 | Status: COMPLETED